Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy

NACompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 31, 2020

Study Completion Date

August 31, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

(dexlan+amox+clar+metr)+(dexlan+amox)

a 7-day quadruple regimen with dexlansoprazole MR 60 mg once daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily, followed by a 7-day dual regimen with dexlansoprazole MR 60 mg once daily and amoxicillin 1 g twice daily

DRUG

dexlan+clarith+amox+metro

dexlansoprazole MR 60 mg once daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily for 14 days

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02646332 - Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy | Biotech Hunter | Biotech Hunter